Contact
searchSearch
HMP Global

July 2013 - FRMC

Department
Foam Approved for Plaque Psoriasis of the Scalp
07/22/2013
The FDA approved Sorilux™ (calcipotriene) Foam as a topical treatment for adults with plaque psoriasis of the scalp.
The FDA approved Sorilux™ (calcipotriene) Foam as a topical treatment for adults with plaque psoriasis of the scalp.
The FDA approved Sorilux™...
07/22/2013
First Report Managed Care
Department
Oral Medication to Treat Myelofibrosis
07/22/2013
The FDA approved Jakafi® (ruxolitinib) in November 2011 to treat patients with myelofibrosis, a bone marrow disease. 
The FDA approved Jakafi® (ruxolitinib) in November 2011 to treat patients with myelofibrosis, a bone marrow disease. 
The FDA approved...
07/22/2013
First Report Managed Care
Department
Simeprevir Phase 3 Trial Results
07/22/2013
Orlando—Treatment-naïve patients with hepatitis C who took 150 mg of simeprevir once daily in combination with peginterferon and ribavirin had a significantly better sustained virological response (SVR) rate compared with those taking...
Orlando—Treatment-naïve patients with hepatitis C who took 150 mg of simeprevir once daily in combination with peginterferon and ribavirin had a significantly better sustained virological response (SVR) rate compared with those taking...
Orlando—Treatment-naïve patients...
07/22/2013
First Report Managed Care
Duration of Treatment with Linaclotide
07/22/2013
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel...
07/22/2013
First Report Managed Care
Lifetime Burden of Inaccurate HER2 Testing
07/22/2013
Chicago—Among the estimated 26,870 women who were diagnosed with breast cancer in 2012, 20% had tumors that overexpress the human epidermal growth factor 2 (HER2) gene, a marker of severity of disease that can influence therapy selection. All...
Chicago—Among the estimated 26,870 women who were diagnosed with breast cancer in 2012, 20% had tumors that overexpress the human epidermal growth factor 2 (HER2) gene, a marker of severity of disease that can influence therapy selection. All...
Chicago—Among the estimated...
07/22/2013
First Report Managed Care

Department

Conference Insider
Treatment Options for Ulcerative Colitis
07/22/2013
Orlando—Clinicians have numerous options to treat patients with ulcerative colitis, a form of inflammatory bowel disease. The therapies include 5-amino-salacylic acid, thiopurine, and anti-tumor necrosis factor (TNF) agents such as...
Orlando—Clinicians have numerous options to treat patients with ulcerative colitis, a form of inflammatory bowel disease. The therapies include 5-amino-salacylic acid, thiopurine, and anti-tumor necrosis factor (TNF) agents such as...
Orlando—Clinicians have numerous...
07/22/2013
First Report Managed Care
Conference Insider
Linaclotide and Improved Abdominal and Bowel Symptoms
07/22/2013
Orlando—An analysis of two phase 3 trials found that a higher percentage of patients who received linaclotide to treat abdominal and bowel symptoms had clinically meaningful improvement compared with a group receiving placebo. The clinically...
Orlando—An analysis of two phase 3 trials found that a higher percentage of patients who received linaclotide to treat abdominal and bowel symptoms had clinically meaningful improvement compared with a group receiving placebo. The clinically...
Orlando—An analysis of two phase...
07/22/2013
First Report Managed Care
Conference Insider
Extended Duration Thromboprophylaxis for Venous Thromboembolism
07/22/2013
Orlando—Patients with venous thromboembolism (VTE) who took extended duration thromboprophylaxis had an incremental cost-effectiveness ratio of $8123 per quality-adjusted life year (QALY), according to a cost-effectiveness decision tree...
Orlando—Patients with venous thromboembolism (VTE) who took extended duration thromboprophylaxis had an incremental cost-effectiveness ratio of $8123 per quality-adjusted life year (QALY), according to a cost-effectiveness decision tree...
Orlando—Patients with venous...
07/22/2013
First Report Managed Care
Conference Insider
Readmission Rates and Gastrointestinal Surgeries
07/22/2013
Orlando—After controlling for patient and operative factors, the authors in a study of patients undergoing major gastrointestinal surgeries found numerous factors were associated with an increased risk of 30-day unplanned readmissions.
Orlando—After controlling for patient and operative factors, the authors in a study of patients undergoing major gastrointestinal surgeries found numerous factors were associated with an increased risk of 30-day unplanned readmissions.
Orlando—After controlling for...
07/22/2013
First Report Managed Care
Conference Insider
Colorectal Cancer Screening and Colonoscopies
07/22/2013
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for...
07/22/2013
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Call for Gastric Surgery to be Standard Diabetes Treatment
05/25/2016
People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication.
People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication.
People with diabetes should be...
05/25/2016
First Report Managed Care
News
Montana Lawmakers Propose New Abortion Regulations for Medicaid Reimbursement
01/24/2023
Under the proposed change, providers would be required to have state approval before performing an abortion and submit supporting documents to demonstrate the procedure's medical necessity.
Under the proposed change, providers would be required to have state approval before performing an abortion and submit supporting documents to demonstrate the procedure's medical necessity.
Under the proposed change,...
01/24/2023
First Report Managed Care
Trends in Coronary Revascularization Procedures
08/22/2011
One of the most common major medical procedures provided by the healthcare system in the United States, coronary revascularization, is performed >1 million times each year. The procedure comprises coronary artery bypass graft (CABG)...
One of the most common major medical procedures provided by the healthcare system in the United States, coronary revascularization, is performed >1 million times each year. The procedure comprises coronary artery bypass graft (CABG)...
One of the most common major...
08/22/2011
First Report Managed Care
News
Insurer wants focus on what drives up health costs
03/28/2011
03/28/2011
First Report Managed Care
News
Takeda’s Successor Drug to Actos Fails to Win Approval
04/26/2012
04/26/2012
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

July 2013 Volume 10 Issue 7

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use